Alpha 2.0
Login Register
» Articles » PMID: 3819789

Clinical Improvement After Administration of Coenzyme Q10 in a Patient with Mitochondrial Encephalomyopathy

Overview
Journal J Neurol
Specialty Neurology
Date 1987 Jan 1
PMID 3819789
Citations 6
Authors
S Goda
T Hamada
S Ishimoto
T Kobayashi
I Goto
Y Kuroiwa
Affiliations
Soon will be listed here.
Abstract

In a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes [MELAS] who had normal mitochondrial enzyme activity, high doses of coenzyme Q10 (CoQ) were administered. Clinical improvement with decreased serum lactate and pyruvate levels was observed. Though the mechanism of action of CoQ is not known, a trial is worthwhile in patients with MELAS.

Citing Articles

Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Bottani E, Lamperti C, Prigione A, Tiranti V, Persico N, Brunetti D Pharmaceutics. 2020; 12(11).

PMID: 33187380 PMC: 7696526. DOI: 10.3390/pharmaceutics12111083.

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Morris G, Anderson G, Berk M, Maes M Mol Neurobiol. 2013; 48(3):883-903.

PMID: 23761046 DOI: 10.1007/s12035-013-8477-8.

Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus.

Zierz S, Jahns G, Jerusalem F J Neurol. 1989; 236(2):97-101.

PMID: 2709060 DOI: 10.1007/BF00314404.

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Shoffner J, Lott M, Voljavec A, Soueidan S, Costigan D, Wallace D Proc Natl Acad Sci U S A. 1989; 86(20):7952-6.

PMID: 2554297 PMC: 298190. DOI: 10.1073/pnas.86.20.7952.

Mitochondrial encephalomyopathy (MELAS) with mental disorder. CT, MRI and SPECT findings.

Suzuki T, Koizumi J, Shiraishi H, Ishikawa N, Ofuku K, Sasaki M Neuroradiology. 1990; 32(1):74-6.

PMID: 2333139 DOI: 10.1007/BF00593949.

References
1.
Skoglund R . Reversible alexia, mitochondrial myopathy, and lactic acidemia. Neurology. 1979; 29(5):717-20. DOI: 10.1212/wnl.29.5.717. View
2.
Pavlakis S, Phillips P, DiMauro S, De Vivo D, Rowland L . Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984; 16(4):481-8. DOI: 10.1002/ana.410160409. View
3.
HART Z, Chang C, PERRIN E, Neerunjun J, Ayyar R . Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Arch Neurol. 1977; 34(3):180-5. DOI: 10.1001/archneur.1977.00500150066013. View
4.
Shapira Y, Cederbaum S, Cancilla P, Nielsen D, Lippe B . Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Neurology. 1975; 25(7):614-21. DOI: 10.1212/wnl.25.7.614. View
5.
Morgan-Hughes J, Hayes D, Clark J, Landon D, Swash M, Stark R . Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain. 1982; 105 (Pt 3):553-82. DOI: 10.1093/brain/105.3.553. View